Motivation and Aim: Currently, the role of the immune system in the pathogenesis of various mental disorders, in particular, chemical and behavioral addictions, is being actively studied. One of the molecular mechanisms underlying neuroimmune interactions, both in normal and pathological conditions, is the commonality of the receptor system of immunocytes and neurons with respect to such signaling molecules as cytokines and neurotransmitters. Of particular interest is the presence of gammaaminobutyric acid (GABA) receptors type A, which are the main target of ethanol in the CNS, also on the surface of T-lymphocytes, which suggests the possibility of direct regulation of the immune response by inhibitory neurotransmitters. According to the modern paradigm, an essential pathogenetic mechanism of chronic alcoholism is neuroinflammation. Moreover, the cellular components of both non-adoptive and adoptive immunity are involved in the pathological process. Molecules of the GABAreceptor (GABA-R) complex, molecules of the Toll-like receptor family (TLRs), and cytokines play a key role in maintaining the pathological state. Ethanol consumption induces stable long-term activation of microglia predominantly in the hippocampus, mediated by TLRs [2]. Recently, an alternative pathway of TLR4 activation mediated by GABA-R has been identified, leading to a change in the balance of pro-and antiinflammatory cytokine ligands on neurons, which is involved in the mechanisms of disturbance of higher nervous activity processes in alcoholism [1]. ortho-Fluorobenzonal is a synthetic ligand of the BDR-GABA-R complex, which, as we have previously established, have immunomodulatory properties mediated by lymphocytic GABA-R [3,4]. The purpose of this work was to study the effect of the synthetic ligands of the GABA-R ortho-fluorobenzonal on the functional activity of the nervous and immune systems in experimental alcoholism. Materials and Methods: Male (CBAxC57Bl/6)F1 mice in the state of alcohol dependence owing to 6-month 10 % ethanol exposure were undergoing intragastric administration of ortho-fluorobenzonal (100 mg/kg for 10 days). ortho-Fluorobenzonal was designed and synthesized in the